- Home
- PAY vs VKTX Comparison
PAY vs VKTX Comparison
Compare PAY & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAY
- VKTX
- Stock Information
- Founded
- PAY 2004
- VKTX 2012
- Country
- PAY United States
- VKTX United States
- Employees
- PAY N/A
- VKTX N/A
- Industry
- PAY Computer Software: Prepackaged Software
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- PAY Technology
- VKTX Health Care
- Exchange
- PAY Nasdaq
- VKTX Nasdaq
- Market Cap
- PAY 3.4B
- VKTX 3.4B
- IPO Year
- PAY 2021
- VKTX 2015
- Fundamental
- Price
- PAY $26.38
- VKTX $25.65
- Analyst Decision
- PAY Hold
- VKTX Strong Buy
- Analyst Count
- PAY 6
- VKTX 11
- Target Price
- PAY $31.83
- VKTX $95.18
- AVG Volume (30 Days)
- PAY 619.5K
- VKTX 4.0M
- Earning Date
- PAY 03-10-2025
- VKTX 04-23-2025
- Dividend Yield
- PAY N/A
- VKTX N/A
- EPS Growth
- PAY 94.45
- VKTX N/A
- EPS
- PAY 0.35
- VKTX N/A
- Revenue
- PAY $871,745,000.00
- VKTX N/A
- Revenue This Year
- PAY $18.50
- VKTX N/A
- Revenue Next Year
- PAY $20.14
- VKTX N/A
- P/E Ratio
- PAY $75.17
- VKTX N/A
- Revenue Growth
- PAY 41.87
- VKTX N/A
- 52 Week Low
- PAY $16.94
- VKTX $24.41
- 52 Week High
- PAY $38.94
- VKTX $82.00
- Technical
- Relative Strength Index (RSI)
- PAY 42.00
- VKTX 37.65
- Support Level
- PAY $26.43
- VKTX $25.80
- Resistance Level
- PAY $28.54
- VKTX $29.60
- Average True Range (ATR)
- PAY 1.72
- VKTX 1.69
- MACD
- PAY 0.01
- VKTX -0.17
- Stochastic Oscillator
- PAY 18.87
- VKTX 17.19
About PAY Paymentus Holdings Inc.
Paymentus Holdings Inc provides electronic bill presentment and payment services, enterprise customer communication and self-service revenue management to billers and financial institutions through a Software-as-a-Service, (SaaS), secure, omni-channel technology platform. The platform integrates into a biller's core financial and operating systems to provide flexible and secure access to payment processing of credit cards, debit cards, eChecks and digital wallets across a number of channels including online, mobile, IVR, call center, chatbot and voice-based assistants. The Company generates revenue from payment transaction fees processed through the Company's platform. The fees are generated as a percentage of transaction value or a specified fee per transaction.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.